These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7802985)

  • 21. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Course of HIV disease does not depend on risk group: 7.5-year follow-up in 296 patients.
    Hengge UR; Franz B; Hoersch S; Goos M
    Int J STD AIDS; 2003 Jul; 14(7):451-7. PubMed ID: 12869224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
    Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
    AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of sex differences in presentation for care of HIV.
    Biber CL; Jaker MA; Kloser P; Auerbach SB; Rhoads GG
    AIDS Patient Care STDS; 1999 Feb; 13(2):103-10. PubMed ID: 11362098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?
    Prins M; Brettle RP; Robertson JR; Hernández Aguado I; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    Int J Epidemiol; 1999 Jun; 28(3):541-9. PubMed ID: 10405862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do HIV disease progression and HAART response vary among injecting drug users in Europe?
    van Asten L; Zangerle R; Hernández Aguado I; Boufassa F; Broers B; Brettle RP; Roy Robertson J; McMenamin J; Coutinho RA; Prins M
    Eur J Epidemiol; 2005; 20(9):795-804. PubMed ID: 16170664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High mortality among HIV-infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modellers?
    van Haastrecht HJ; van den Hoek AJ; Coutinho RA
    AIDS; 1994 Mar; 8(3):363-6. PubMed ID: 8031515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.
    Raffetti E; Postorino MC; Castelli F; Casari S; Castelnuovo F; Maggiolo F; Di Filippo E; D'Avino A; Gori A; Ladisa N; Di Pietro M; Sighinolfi L; Zacchi F; Torti C
    BMC Public Health; 2016 Aug; 16(1):878. PubMed ID: 27557878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
    Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
    Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem.
    Diaz T; Vlahov D; Greenberg B; Cuevas Y; Garfein R
    J Womens Health Gend Based Med; 2001 May; 10(4):371-80. PubMed ID: 11445028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
    Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
    Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
    Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
    Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
    Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
    Eur J Med Res; 1996 Jan; 1(4):209-14. PubMed ID: 9445761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
    Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
    J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.